4//SEC Filing
Sandison Taylor 4
Accession 0001610618-22-000079
CIK 0001610618other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 6:51 PM ET
Size
8.8 KB
Accession
0001610618-22-000079
Insider Transaction Report
Form 4
Sandison Taylor
Chief Medical Officer
Transactions
- Sale
Common Stock
2022-09-12$0.68/sh−18,478$12,656→ 291,753 total
Footnotes (2)
- [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on September 10, 2022. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- [F2]Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2022.
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0001702287
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 6:51 PM ET
- Size
- 8.8 KB